Abstract
The prevalence of coronary hyper-intense plaques (CHIPs) and the plaque-to-myocardium signal intensity ratio (PMR) are positively associated with disease severity and high-risk plaque morphology in patients with acute coronary syndrome (ACS).
Introduction
Acute Coronary Syndrome (ACS) remains a leading cause of sudden cardiac death, typically precipitated by the rupture of vulnerable atherosclerotic plaques and subsequent thrombus formation. While invasive imaging like Optical Coherence Tomography (OCT) is the gold standard for identifying high-risk plaque features, its invasive nature limits widespread application. Cardiovascular Magnetic Resonance (CMR) offers a non-invasive alternative, specifically through T1-weighted imaging which can detect CHIPs—markers of intra-plaque hemorrhage or thrombus. This study investigates the correlation between MRI-identified CHIPs and the clinical severity of ACS.
Methods: The CATCH Technique
Researchers employed a novel CMR sequence known as CATCH (Coronary Atherosclerosis T1w Characterization with integrated anatomical reference). This technique addresses traditional CMR limitations by using a motion-corrected, interleaved sequence that simultaneously generates "dark-blood" images (to highlight plaques) and "bright-blood" images (for anatomical context).
The primary metric used was the Plaque-to-Myocardium signal intensity Ratio (PMR). A plaque was classified as a CHIP if its PMR exceeded 1.4. Findings were validated against invasive OCT in a patient sub-group to identify high-risk features such as plaque rupture, thrombus, and thin-cap fibroatheroma (TCFA).
Study Population and Datasets
The prospective study enrolled 62 patients with known or suspected coronary artery disease. The cohort was divided into an ACS group (n=50) and a stable angina pectoris (SAP) control group (n=12). The ACS group was further stratified by clinical severity into unstable angina (UAP), non-ST-segment-elevation myocardial infarction (NSTEMI), and ST-segment-elevation myocardial infarction (STEMI).
Key Results
The study revealed a significant "dose-response" relationship between plaque signal intensity and clinical severity:
- Prevalence of CHIPs: The frequency of CHIPs increased significantly with disease severity: 8% in SAP, 26% in UAP, 38% in NSTEMI, and 67% in STEMI (p=0.009).
- Signal Intensity Trends: Median PMR values peaked at 1.6 in STEMI patients, compared to 1.1 in the stable group (p=0.004).
- Pathological Correlation: CHIPs served as highly specific markers for biological danger. Compared to non-hyper-intense plaques, CHIPs were nearly five times more likely to contain a thrombus (88% vs. 18%, p=0.001) and seven times more likely to exhibit plaque rupture (63% vs. 9%, p=0.007).
- Quantitative Risk Scaling: A positive correlation (r=0.44) was found between PMR values and the number of high-risk features identified by OCT, suggesting that higher signal intensity reflects greater plaque vulnerability.
Discussion and Limitations
These findings suggest that CATCH MRI can serve as a "one-stop" non-invasive tool for cardiac risk assessment by identifying high-risk plaques that correlate with clinical severity. However, the study is limited by a small sample size (n=62) and potential selection bias, as the most acute patients requiring emergency intervention were excluded. Additionally, the 48-hour window between MRI and OCT may introduce temporal discrepancies in thrombus characterization. Future research should focus on larger multi-center trials to determine if PMR can predict future major adverse cardiac events (MACE).
Summary updated